Characteristics | All patients (N = 60) | Characteristics | All patients (N = 60) | ||
No. | % | No. | % | ||
Sex |
|
| Distant metastasis |
|
|
Male | 36 | 60% | Absent | 43 | 71.7% |
Female | 24 | 40% | Present | 17 | 28.3% |
Age year |
|
| Duke’s stage |
|
|
Mean ± SD | 58.33 | ±12.27 | Stage A | 14 | 23.3% |
Median (Range) | 60 | (29 - 80) | Stage B | 11 | 18.3% |
Initial site |
|
| Stage C | 18 | 30% |
Ascending | 19 | 31.7% | Stage D | 17 | 28.3% |
Transverse | 6 | 10% | AJCC stage |
|
|
Descending | 5 | 8.3% | Stage I | 14 | 23.3% |
Rectosigmoid | 30 | 50% | Stage II | 12 | 20% |
Size |
|
| Stage III | 17 | 28.3% |
≤5 cm | 27 | 45% | Stage IV | 17 | 28.3% |
>5 cm | 33 | 55% | Response to treatment | (N = 22) | |
Pathological type |
|
| PD | 8 | 36.4% |
Conventional | 52 | 86.7% | SD | 6 | 27.3% |
Mucoid | 8 | 13.3% | PR | 3 | 13.6% |
Grade |
|
| CR | 5 | 22.7% |
Grade I | 13 | 21.7% | Follow-up months |
|
|
Grade II | 31 | 51.7% | Mean ± SD | 23.11 | ±9.98 |
Grade III | 16 | 26.7% | Median (Range) | 25 | (8 - 35) |
T |
|
| Relepase | (N = 42) | |
T1 | 9 | 15% | Absent | 28 | 66.7% |
T2 | 14 | 23.3% | Present | 14 | 33.3% |
T3 | 12 | 20% |
|
|
|
T4 | 25 | 41.7% |
|
|
|
LN metastasis |
|
| Death |
|
|
Node negative | 26 | 43.3% | Alive | 40 | 66.7% |
Node positive | 34 | 56.7% | Died | 20 | 33.3% |